Growth of healthy term infants fed ready-to-feed and powdered forms of an extensively hydrolyzed casein-based infant formula: a randomized, blinded, controlled trial

Clin Pediatr (Phila). 2014 Jun;53(6):585-92. doi: 10.1177/0009922814528036. Epub 2014 Mar 24.

Abstract

Extensively hydrolyzed formulas present a complex matrix subject to adverse conditions during manufacture that could influence growth and tolerance of infants fed these formulas. A masked, randomized, parallel growth study was conducted in infants fed a ready-to-feed (RTF) or powdered (PWD) form of an extensively hydrolyzed casein-based formula. Infants were enrolled between 0 and 9 days and studied to 112 days of age. Growth, formula intake, and stool patterns were assessed. There were no significant differences between groups in weight, length, head circumference, or their respective gains. Tolerance was similar between groups except that the RTF group had greater formula intakes and passed more stools/day compared to the PWD group. This study demonstrates that the PWD formulation of this RTF formula supports similar growth and tolerance in infants during the first 4 months of life.

Keywords: Maillard browning; formula; hydrolysate formula; hypoallergenic; infant feeding; infant growth; weight.

Publication types

  • Randomized Controlled Trial
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Body Height
  • Body Weight
  • Caseins*
  • Female
  • Humans
  • Infant Formula / administration & dosage
  • Infant Formula / chemistry*
  • Infant*
  • Infant, Newborn / growth & development*
  • Male
  • Powders
  • Term Birth

Substances

  • Caseins
  • Powders
  • casein hydrolysate